Federal Register / Vol. 89, No. 197 / Thursday, October 10, 2024 / Notices 82271 

and did not otherwise avail itself of the 

opportunity to refute the Government’s 

case. As such, Registrant has made no 

representations as to its future 

compliance with the CSA nor made any 

demonstration that it can be entrusted 

with registration. Moreover, the 

evidence presented by the Government 

shows that Registrant violated the CSA, 

further indicating that Registrant cannot 

be entrusted. 

Accordingly, the Agency will order 

the revocation of Registrant’s 

registration. 

Order 

Pursuant to 28 CFR 0.100(b) and the 

authority vested in me by 21 U.S.C. 

824(a), I hereby revoke DEA Certificate 

of Registration No. FH9037830 issued to 

Halowells Pharmacy. Further, pursuant 

to 28 CFR 0.100(b) and the authority 

vested in me by 21 U.S.C. 823(g)(1), I 

hereby deny any pending applications 

of Halowells Pharmacy to renew or 

modify this registration, as well as any 

other pending application of Halowells 

Pharmacy for additional registration in 

Texas. This Order is effective November 

12, 2024. 

Signing Authority 

This document of the Drug 

Enforcement Administration was signed 

on October 4, 2024, by Administrator 

Anne Milgram. That document with the 

original signature and date is 

maintained by DEA. For administrative 

purposes only, and in compliance with 

requirements of the Office of the Federal 

Register, the undersigned DEA Federal 

Register Liaison Officer has been 

authorized to sign and submit the 

document in electronic format for 

publication, as an official document of 

DEA. This administrative process in no 

way alters the legal effect of this 

document upon publication in the 

Federal Register. 

Heather Achbach, 

Federal Register Liaison Officer, Drug 

Enforcement Administration. 

[FR Doc. 2024–23495 Filed 10–9–24; 8:45 am] 

BILLING CODE 4410–09–P 

NATIONAL SCIENCE FOUNDATION 

Agency Information Collection 

Activities: Comment Request; Louis 

Stokes Alliances for Minority 

Participation (LSAMP) Program 

Evaluation; Withdrawal 

AGENCY: National Science Foundation 

(NSF). 

ACTION: Notice; withdrawal. 

SUMMARY: The National Science 

Foundation published a notice in the 

Federal Register on September 23, 2024, 

that was inadvertently sent forward to 

publish and is a duplicate (with errors) 

of a notice published on October 2, 

2024. 

FOR FURTHER INFORMATION CONTACT: 

Suzanne H. Plimpton, Reports Clearance 

Officer, National Science Foundation, 

2415 Eisenhower Avenue, Alexandria, 

Virginia 22314; telephone (703) 292– 

7556; or send email to splimpto@

nsf.gov. Individuals who use a 

telecommunications device for the deaf 

(TDD) may call the Federal Information 

Relay Service (FIRS) at 1–800–877– 

8339, which is accessible 24 hours a 

day, 7 days a week, 365 days a year 

(including federal holidays). 

SUPPLEMENTARY INFORMATION: 

Background 

On September 23, 2024, the National 

Science Foundation published in the 

Federal Register a notice for comments 

(FR Doc 2024–21845) that was 

inadvertently published (with errors) 

and is a duplicate of a notice published 

October 2, 2024 (FR Doc 2024–22588). 

Retraction 

From the Federal Register of 

September 23, 2024, the notice in the 

second column of page 77898 to the 

second column of 77899, is withdrawn 

(FR Doc 2024–21845). As such, FR Doc 

2024–21845 should be disregarded. 

Dated: October 4, 2024. 

Suzanne H. Plimpton, 

Reports Clearance Officer, National Science 

Foundation. 

[FR Doc. 2024–23420 Filed 10–9–24; 8:45 am] 

BILLING CODE 7555–01–P 

NUCLEAR REGULATORY 

COMMISSION 

720th Meeting of the Advisory 

Committee on Reactor Safeguards 

(ACRS) 

In accordance with the purposes of 

sections 29 and 182b of the Atomic 

Energy Act (42 U.S.C. 2039, 2232(b)), 

the Advisory Committee on Reactor 

Safeguards (ACRS) will hold meetings 

on November 6–8, 2024. The Committee 

will be conducting meetings that will 

include some Members being physically 

present at the NRC while other Members 

participate remotely. Interested 

members of the public are encouraged to 

participate remotely in any open 

sessions via MS Teams or via phone at 

301–576–2978, passcode 887 935 620#. 

A more detailed agenda including the 

MSTeams link may be found at the 

ACRS public website at https://

www.nrc.gov/reading-rm/doccollections/acrs/agenda/index.html. If 

you would like the MSTeams link 

forwarded to you, please contact the 

Designated Federal Officer (DFO) as 

follows: Quynh.Nguyen@nrc.gov, or 

Lawrence.Burkhart@nrc.gov. 

Wednesday, November 6, 2024 

8:30 a.m.–8:35 a.m.: Opening 

Remarks by the ACRS Chair (Open)— 

The ACRS Chair will make opening 

remarks regarding the conduct of the 

meeting. 

8:35 a.m.–10:30 a.m.: Draft White 

Paper, ‘‘Nth-of-a-Kind Micro-Reactor 

Licensing and Deployment 

Considerations’’ (Open)—The 

Committee will have presentations and 

discussion with the NRC staff regarding 

the subject topic. 

10:30 a.m.–1:00 p.m.: Committee 

Deliberation on Draft White Paper, 

‘‘Nth-of-a-Kind Micro-Reactor Licensing 

and Deployment Considerations’’ 

(Open)—The Committee will deliberate 

with the NRC staff regarding the subject 

topic. 

1:00 p.m.–6:00 p.m.: Triennial Review 

and Evaluation of NRC Safety Research 

Program/Preparation of Reports 

(Open)—The Committee will have 

presentations and discussion with the 

NRC staff regarding the subject topic. 

Thursday, November 7, 2024 

8:30 a.m.–10:15 a.m.: TerraPower 

Natrium Topical Report on Plume 

Exposure Pathway Emergency Planning 

Zone (Open/Closed)—The Committee 

will have presentations and discussion 

with the NRC staff regarding the subject 

topic. 

[Note: Pursuant to 5 U.S.C. 552b(c)(4), 

a portion of this session may be closed 

in order to discuss and protect 

information designated as proprietary.] 

10:15 a.m.–11:15 a.m.: Committee 

Deliberation on the TerraPower Natrium 

Topical Report on Plume Exposure 

Pathway Emergency Planning Zone 

(Open/Closed)—The Committee will 

deliberate with the NRC staff regarding 

the subject topic. 

[Note: Pursuant to 5 U.S.C. 552b(c)(4), 

a portion of this session may be closed 

in order to discuss and protect 

information designated as proprietary.] 

1:15 p.m.–6:00 p.m.: Planning and 

Procedures Session/Future ACRS 

Activities/Reconciliation of ACRS 

Comments and Recommendations/ 

Preparation of Reports (Open/Closed)— 

The Committee will hear discussion of 

the recommendations of the Planning 

and Procedures Subcommittee regarding 

items proposed for consideration by the 


lotter on DSK11XQN23PROD with NOTICES1